Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Caris Life Sciences Inc.

    NASDAQ: CAI · Real-Time Price · USD
    36.05
    -0.88 (-2.38%)
    At close: Aug 20, 2025, 10:08 AM

    Caris Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 100.83M 85.69M 80.8M
    Cost of Revenue
    		 46.74M 42.83M 42.21M
    Gross Profit
    		 54.09M 42.87M 38.59M
    Operating Income
    		 66.44M 50.84M 48.76M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 54.83M 39.8M 37.18M
    Net Income
    		 51.16M 37.94M 35.74M
    Selling & General & Admin
    		 12.29M 10.17M 7.74M
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 12.29M 10.17M 7.74M
    Interest Expense
    		 n/a 11.11M 11.17M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 59.03M 53M 49.95M
    Income Tax Expense
    		 3.68M 1.86M 2.5M
    Shares Outstanding (Basic)
    		 17.34M 17.28M 17.27M
    Shares Outstanding (Diluted)
    		 17.53M 17.48M 17.52M
    EPS (Basic)
    		 2.95 2.20 2.07
    EPS (Diluted)
    		 2.92 2.17 2.04
    EBITDA
    		 87.72M 80.39M 78.18M
    EBIT
    		 n/a 50.91M 48.35M
    Depreciation & Amortization
    		 32.88M 29.48M 28.77M

    Add to Watchlist